Sanofi Loses Bid To Dismiss Claims Over Arava
A judge has denied Sanofi-Aventis' motion to dismiss antitrust claims accusing the company of unlawfully blocking generic competition for Sanofi's rheumatoid arthritis treatment Arava by filing a sham Citizen Petition with...To view the full article, register now.
Already a subscriber? Click here to view full article